Invention Grant
- Patent Title: Immunogenic compositions for use in pneumococcal vaccines
-
Application No.: US15542802Application Date: 2016-01-05
-
Publication No.: US10653764B2Publication Date: 2020-05-19
- Inventor: David Cooper , Kathrin Ute Jansen , Michael William Pride
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Keith D. Hutchinson; Matthew J. Pugmire
- International Application: PCT/IB2016/050036 WO 20160105
- International Announcement: WO2016/113644 WO 20160721
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/116 ; A61K39/00 ; A61K39/09 ; A61K39/385
Abstract:
An object of the present invention is to provide immunogenic compositions for protection against S. pneumoniae, in particular against S. pneumoniae serogroup 9, while limiting the number of conjugates. The present invention thereforerelates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said immunogenic compositions.
Public/Granted literature
- US20180000922A1 Immunogenic Compositions for Use in Pneumococcal Vaccines Public/Granted day:2018-01-04
Information query
